Skip to content
10-Q

Quarterly Report

PetLife Pharmaceuticals, Inc.

0001493152-18-010103

← back to feed
Filed
Jul 17, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Jul 9, 2018 196.75M sh
Operating Cash Flow Q2 2018 · Feb 28, 2018 −$282.4K
Operating Cash Flow Q2 2018 · Feb 28, 2017 −$339.41K
Cash And Equivalents Q2 2018 · Feb 28, 2018 $7.86K
Cash And Equivalents Q2 2018 · Aug 31, 2017 $54.25K
Cash And Equivalents Q2 2018 · Feb 28, 2017 $445
Cash And Equivalents Q2 2018 · Aug 31, 2016 $1.17K
Stockholders Equity Q2 2018 · Feb 28, 2018 −$1.97M
Stockholders Equity Q2 2018 · Aug 31, 2017 −$1.38M
Current Liabilities Q2 2018 · Feb 28, 2018 $1.98M
Current Liabilities Q2 2018 · Aug 31, 2017 $1.44M
Total Liabilities Q2 2018 · Feb 28, 2018 $1.98M
Total Liabilities Q2 2018 · Aug 31, 2017 $1.44M
Current Assets Q2 2018 · Feb 28, 2018 $7.86K
Current Assets Q2 2018 · Aug 31, 2017 $55K
Total Assets Q2 2018 · Feb 28, 2018 $7.86K
Total Assets Q2 2018 · Aug 31, 2017 $55K
Net Income Q2 2018 · Feb 28, 2018 −$427.06K
Net Income Q2 2018 · Feb 28, 2018 −$893.72K
Net Income Q2 2018 · Feb 28, 2017 −$1.32M
Net Income Q2 2018 · Feb 28, 2017 −$20.44M
Operating Income Q2 2018 · Feb 28, 2018 −$182.67K
Operating Income Q2 2018 · Feb 28, 2018 −$375.98K
Operating Income Q2 2018 · Feb 28, 2017 −$1.25M
Operating Income Q2 2018 · Feb 28, 2017 −$20.37M